A normal CA 125 result is typically below 35 units per milliliter (U/mL). This value reflects the concentration of a glycoprotein antigen in the blood associated with epithelial ovarian cancer, though it is not diagnostic on its own.
CA 125 is measured through a blood test called serum CA 125. The test detects levels of a protein produced by certain cells, including those in the lining of the uterus and fallopian tubes. While elevated levels may signal ovarian cancer, especially in postmenopausal women, many non-cancerous conditions can raise CA 125 too.
For example, endometriosis, pelvic inflammatory disease, liver cirrhosis, and even menstruation can cause temporary increases. A single elevated result does not indicate cancer. Instead, doctors use trends over time and clinical context to interpret results.
CA 125 is not a screening tool for healthy individuals. It's primarily used to monitor known ovarian cancer or assess symptoms like abdominal swelling, bloating, or pelvic pain. A level below 35 U/mL is considered within the normal range for most adults.
Levels above 35 U/mL are considered elevated. However, only about 50% of early-stage ovarian cancers show elevated CA 125. By stage III or IV, that rises to around 80%. This means a normal result doesn't rule out cancer, and an abnormal result doesn't confirm it.
Some labs use slightly different reference ranges. For instance, one lab may define normal as under 40 U/mL. Always compare your result to the lab's specific reference range listed on the report. A result of 36 U/mL may be flagged as high in one facility and normal in another.
CA 125 results fall into three categories based on clinical interpretation:
| Result Category | CA 125 Level (U/mL) | Clinical Implication |
|---|---|---|
| Normal | < 35 | No evidence of active ovarian cancer. May still require monitoring if symptoms persist. |
| Elevated | 35-100 | May suggest benign condition. Requires follow-up imaging or repeat testing. |
| High | > 100 | Stronger association with ovarian cancer. Often triggers further investigation like transvaginal ultrasound or biopsy. |
For example, a patient with persistent bloating and a CA 125 of 68 U/mL would prompt a gynecologic oncologist to order a pelvic MRI. If imaging shows a complex ovarian mass, surgery may be recommended. But if no mass appears, the elevation likely stems from endometriosis or inflammation.
CA 125 is not useful in premenopausal women unless there's a strong family history of ovarian cancer or a known genetic mutation like BRCA1/BRCA2. In this group, false positives are common due to hormonal fluctuations and benign conditions.
Many patients assume a high CA 125 means they have cancer. That's incorrect. A study published in the Journal of the National Cancer Institute found that only 12% of women with CA 125 above 100 U/mL were diagnosed with ovarian cancer after further evaluation.
Another misconception is that CA 125 is a reliable screening tool. The U.S. Preventive Services Task Force (USPSTF) concluded in 2014 that routine CA 125 screening in asymptomatic women leads to more harm than benefit. False positives lead to unnecessary surgeries, anxiety, and complications.
CA 125 is often confused with CA 15-3, which monitors breast cancer. These are distinct markers. CA 125 is specific to epithelial ovarian tumors and related tissues. It is not used for lung, colon, or prostate cancers.
I once reviewed a case where a 52-year-old woman had a CA 125 of 140 U/mL. She was anxious until we discovered she had active endometriosis confirmed via laparoscopy. After treatment, her CA 125 dropped to 28 U/mL. This illustrates how important context is.
If your CA 125 is elevated but you have no symptoms, your doctor may recommend repeating the test in 4-6 weeks. A rising trend over time is more concerning than a single high value.
For patients undergoing treatment for ovarian cancer, CA 125 is tracked every 3 months during chemotherapy. A drop of 50% or more after two cycles correlates with better survival outcomes. Conversely, a rising level may indicate disease progression.
For women with a history of ovarian cancer, a stable or declining CA 125 suggests remission. A rise above baseline, even if still below 35 U/mL, may trigger imaging to detect recurrence.
Understanding what is a normal CA 125 result requires knowing both the number and the story behind it. A value below 35 U/mL is generally reassuring, but it doesn't eliminate risk. Elevated levels demand careful evaluation-not panic.